Catherine Mummery

8PUBLICATIONS

86CO-AUTHORS

AutoimmunityMechanobiologyMedical devicesBiologically active moleculesGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 15, 2026

Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

|Mar 05, 2026

The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial.

Catherine J Mummery, Arthur J Mayorga, Adam Simmons

|Feb 11, 2026

Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's disease.

Melanie Shulman, Shuang Wu, Nick Ziogas

|Dec 13, 2025

Lecanemab appropriate use recommendations for clinical practice in the UK.

Catherine J Mummery, Jill Rasmussen, Dan Blackburn

|Feb 20, 2025

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.

Randall J Bateman, Yan Li, Eric M McDade

|Oct 16, 2023

Author Correction: Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

Pageof 2

Frequent Collaborators

Simon Ducharme

Juha O Rinne

Eric E Swayze

Daniel A Norris

Alison A Goate

Brian A Gordon

Tammie L S Benzinger

Nick Fox

Jorge J Llibre-Guerra

2 joint publications

Eric McDade

Frequent Collaborators

Simon Ducharme

Juha O Rinne

Eric E Swayze

Daniel A Norris